Depression and Hypothalamic-Pituitary-Adrenal Activation: A Quantitative Summary of Four Decades of Research
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Objectives To summarize quantitatively the literature comparing hypothalamic-pituitary-adrenal (HPA) axis function between depressed and nondepressed individuals and to describe the important sources of variability in this literature. These sources include methodological differences between studies, as well as demographic or clinical differences between depressed samples. Methods The current study used meta-analytic techniques to compare 671 effect sizes (cortisol, adrenocorticotropic hormone, or corticotropin-releasing hormone) across 361 studies, including 18,454 individuals. Results Although depressed individuals tended to display increased cortisol (d = 0.60; 95% confidence interval [CI], 0.54-0.66) and adrenocorticotropic hormone levels (d = 0.28; 95% CI, 0.16-0.41), they did not display elevations in corticotropin-releasing hormone (d = 0.02; 95% CI, -0.47-0.51). The magnitude of the cortisol effect was reduced by almost half (d = 0.33; 95% CI, 0.21-0.45) when analyses were limited to studies that met minimal methodological standards. Gender did not significantly modify any HPA outcome. Studies that included older hospitalized individuals reported significantly greater cortisol differences between depressed and nondepressed groups compared with studies with younger outpatient samples. Important cortisol differences also emerged for atypical, endogenous, melancholic, and psychotic forms of depression. Conclusions The current study suggests that the degree of HPA hyperact…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additional studies on the pathological mechanism of depression have suggested that the HPA axis is hyperactive in MDD patients and that sensitivity to negative feedback is decreased. 15”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [15]
In the citing paper
“Chronic hyperactivation of the stress system is related to hypersecretion of corticotropin releasing hormone and arginine-vasopressin (CRH, AVP) by the hypothalamus and ACTH hypersecretion by the pituitary (76), resulting in higher circulating cortisol levels due also to an “insensitive” negative glucocorticoid (GC) feedback of the HPA axis loop (77).”
From Developmental Trajectories of Early Life Stress and Trauma: A Narrative Review on Neurobiological Aspects Beyond Stress System Dysregulation (2019) · cites this paper as [77]
In the citing paper
“A further metaanalysis of 18,374 adult individuals found higher cortisol in MDD when measured continuously throughout the day, with morning times revealing the least difference between the groups.”
From Childhood Trauma, the HPA Axis and Psychiatric Illnesses: A Targeted Literature Synthesis (2022) · cites this paper as [158]
In the citing paper
“Post DST, higher cortisol and reduced ACTH were found with MDD compared to non-depressed in a metanalysis of 1,639 adults (158).”
From Childhood Trauma, the HPA Axis and Psychiatric Illnesses: A Targeted Literature Synthesis (2022) · cites this paper as [158]
In the citing paper
“ACTH was also higher overall in MDD patients; however, there was no difference between control and depressed patients at any one time of day (158).”
From Childhood Trauma, the HPA Axis and Psychiatric Illnesses: A Targeted Literature Synthesis (2022) · cites this paper as [158]
14 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences (2nd ed.).
Lachenbruch, P. A., & Cohen, J. (1989) · Journal of the American Statistical Association · doi:10.2307/2290095 · Cited by 37,395
Dickerson, S. S., & Kemeny, M. E. (2004) · Psychological Bulletin · doi:10.1037/0033-2909.130.3.355 · Cited by 5,881
Statistical Methods for Meta-Analysis.
Freeman, P. R., Hedges, L. V., & Olkin, I. (1986) · Biometrics · doi:10.2307/2531069 · Cited by 4,784
Fixed-and random-effects models in meta-analysis.
Hedges, L. V., & Vevea, J. L. (1998) · Psychological Methods · doi:10.1037/1082-989x.3.4.486 · Cited by 2,977
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
Miller, G. E., Chen, E., & Zhou, E. S. (2007) · Psychological Bulletin · doi:10.1037/0033-2909.133.1.25 · Cited by 2,467 · cited 1×
“This is important because it is these processes, rather than increased cortisol levels, that are more closely linked to disease outcomes (18,35).”
BackgroundSelf-citationThe HPA axis in major depression: classical theories and new developments
Pariante, C. M., & Lightman, S. L. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.006 · Cited by 2,009
Cortisol levels during human aging predict hippocampal atrophy and memory deficits
Lupien, S. J., de Leon, M., de Santi, S., Convit, A., Tarshish, C., Nair, N. P. V., Thakur, M., McEwen, B. S., Hauger, R. L., & Meaney, M. J. (1998) · Nature Neuroscience · doi:10.1038/271 · Cited by 1,653 · cited 1×
“These individuals are, therefore, more likely to be at risk for conditions where excessive cortisol is thought to play a pathogenic role, such as Type II diabetes, osteoporosis, or dementia (33,34).”
BackgroundGold, P. W., & Chrousos, G. P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001032 · Cited by 1,274
Depression and cortisol responses to psychological stress: A meta-analysis
Burke, H. M., Davis, M. C., Otte, C., & Mohr, D. C. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.02.010 · Cited by 1,194
Cited by
Items 201–300 of 1,305
Amygdala substructure volumes in Major Depressive Disorder
Roddy, D., Kelly, J. R., Farrell, C., Doolin, K., Roman, E., Nasa, A., Frodl, T., Harkin, A., O'Mara, S., O'Hanlon, E., et al. (2021) · NeuroImage: Clinical · doi:10.1016/j.nicl.2021.102781 · Cited by 75
“This is of relevance to MDD because overdrive in the hypothalamic–pituitaryadrenal (HPA) axis has been established in subgroups of MDD (Doolin et al., 2017; Stetler and Miller, 2011).”
BackgroundIs there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder
Young, J. J., Silber, T., Bruno, D., Galatzer-Levy, I. R., Pomara, N., & Marmar, C. R. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00072 · Cited by 71
“A recent meta-analysis (33) reports a significant association between HPA-axis hyperactivity as measured by elevated cortisol levels and the presence of melancholic or psychotic depression while lower cortisol levels were characteristic of depression with atypical features.”
BackgroundEsmaeili, M. H., Bahari, B., & Salari, A. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.01.001 · Cited by 85
Microbiome and Mental Health, Specifically as It Relates to Adolescents
Simkin, D. R. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1075-3 · Cited by 85
Progress and challenges in research of the mechanisms of anhedonia in major depressive disorder
Su, Y., & Si, T. (2022) · General Psychiatry · doi:10.1136/gpsych-2021-100724 · Cited by 85
Workman, J. L., Gobinath, A. R., Kitay, N. F., Chow, C., Brummelte, S., & Galea, L. A. M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.11.027 · Cited by 84
LaGrotte, C., Fernandez-Mendoza, J., Calhoun, S. L., Liao, D., Bixler, E. O., & Vgontzas, A. N. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.87 · Cited by 77
Encore: Behavioural animal models of stress, depression and mood disorders
Petković, A., & Chaudhury, D. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.931964 · Cited by 85
“Such findings are contrary to the observations in human patients and mice that undergo other stress paradigms (Stetler and Miller, 2011).”
ResultChen, C., Nakagawa, S., Kitaichi, Y., An, Y., Omiya, Y., Song, N., Koga, M., Kato, A., Inoue, T., & Kusumi, I. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.03.008 · Cited by 83
“Further, patients suffering from depression have hyper-responsive CORT in the dexamethasone/CRH test (Stetler and Miller 2011) and demonstrate higher CORT during the recovery period after stress (Burke et al 2005), which are also normalized after successful antidepressant treatment (Holsboer and…”
BackgroundThe Role of Saliva Cortisol Measurement in Health and Disease
(2012) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/97816080534211120101 · Cited by 73
Ortiz, J. B., & Conrad, C. D. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.02.005 · Cited by 80
NR3C1 hypermethylation in depressed and bullied adolescents
Efstathopoulos, P., Andersson, F., Melas, P. A., Yang, L. L., Villaescusa, J. C., Rȕegg, J., Ekström, T. J., Forsell, Y., Galanti, M. R., & Lavebratt, C. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0169-8 · Cited by 67
Huffziger, S., Ebner-Priemer, U., Zamoscik, V., Reinhard, I., Kirsch, P., & Kuehner, C. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.04.014 · Cited by 79
“In acute depressive states, a substantial subgroup of patients shows hyperactivation of the HPAA with elevated basal cortisol (Stetler and Miller, 2011).”
BackgroundEarly-Life Stress: From Neuroendocrine Mechanisms to Stress-Related Disorders
Pervanidou, P., & Chrousos, G. P. (2018) · Hormone Research in Paediatrics · doi:10.1159/000488468 · Cited by 69
Inflammation, stress and depression: An exploration of ketamine’s therapeutic profile
Johnston, J. N., Greenwald, M. S., Henter, I. D., Kraus, C., Mkrtchian, A., Clark, N. G., Park, L. T., Gold, P. W., Zarate, C. A., & Kadriu, B. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103518 · Cited by 79
Biomarkers for Depression: Recent Insights, Current Challenges and Future Prospects
Strawbridge, R., Young, A. H., & Cleare, A. J. (2018) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.16206 · Cited by 78
“104,105 This is supported by a recent review of chronic cortisol levels measured in hair, supporting the hypothesis of cortisol hyperactivity in depression but hypoactivity in other illnesses such as panic disorder.”
Maripuu, M., Wikgren, M., Karling, P., Adolfsson, R., & Norrback, K.-F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098682 · Cited by 69
“This might partly explain, why in research on depressive symptomatology in unipolar and bipolar disorders, HPA-axis hyperactivity has been the main focus of attention and consistently reported [10–16].”
Krkovic, K., Clamor, A., & Lincoln, T. M. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.04.028 · Cited by 77
Steroid secretion in healthy aging
Fiacco, S., Walther, A., & Ehlert, U. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.09.035 · Cited by 78
Maternal depression and inflammation during pregnancy
Lahti‐Pulkkinen, M., Girchenko, P. V., Robinson, R., Lehto, S. M., Toffol, E., Heinonen, K., Reynolds, R. M., Kajantie, E., Laivuori, H. M., Villa, P., et al. (2019) · Psychological Medicine · doi:10.1017/s0033291719001909 · Cited by 77
“Glucocorticoid functioning is also closely associated with depression and obesity (Stetler and Miller, 2011; Boggero et al., 2017; Milaneschi et al., 2019).”
BackgroundPerinatal depression and infant and toddler neurodevelopment: A systematic review and meta-analysis
Fan, X., Ni, W., Tu, Y., Zang, T., Bai, J., Peng, G., & Liu, Y. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105579 · Cited by 76
Siegrist, J., & Wege, N. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00066 · Cited by 76
Sebastiani, G., Andreu-Férnández, V., Barbero, A. H., Aldecoa‐Bilbao, V., Echegoyen, X. M., Barrabes, E. M., Ibañez, A. B., Astals, M., Martínez, S. F., Gómez‐Roig, M. D., et al. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.00587 · Cited by 76
“Furthermore, elevated levels of cortisol described in patients with EDs have been associated with most forms of depression (171).”
BackgroundDu, X., Leang, L., Mustafa, T., Renoir, T., Pang, T. Y., & Hannan, A. J. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.58 · Cited by 75
Juruena, M. F., Baes, C. V. W., Menezes, I. C., & Graeff, F. G. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150105125500 · Cited by 75
Mocking, R. J. T., Ruhé, H. G., Assies, J., Lok, A., Koeter, M. W. J., Visser, I., Bockting, C., & Schene, A. H. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.01.013 · Cited by 75
“Although mixed results exist, the extensive literature on cortisol in MDD mainly shows that MDD-patients exhibit higher cortisol concentrations than healthy controls (Stetler and Miller, 2011; Herbert, 2012), both during MDD-episodes and in remission, suggesting an endophenotype (Lok et al.”
Spanemberg, L., Caldieraro, M., Arrua Vares, E., Wollenhaupt de Aguiar, B., Yuri Kawamoto, S., Parker, G., Pio Fleck, M., Kauer-SantAnna, M., & Galvao, E. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s66504 · Cited by 66
Bakusic, J., Vrieze, E., Ghosh, M., Bekaert, B., Claes, S. J., & Godderis, L. (2020) · Neurobiology of Stress · doi:10.1016/j.ynstr.2020.100272 · Cited by 75
“Whereas studies investigating diurnal cortisol or HPA axis response to a chemical stressor (such as dexamethasone suppression test) in MDD more commonly reported HPA axis hyperactivity (Pariante and Lightman, 2008) (Stetler and Miller, 2011) (Knorr et al.”
BackgroundHypothalamic–pituitary–adrenal axis activity in older persons with and without a depressive disorder
Rhebergen, D., Korten, N. C. M., Penninx, B. W. J. H., Stek, M. L., van der Mast, R. C., Voshaar, R. C. O., & Comijs, H. C. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.10.005 · Cited by 75
T Cell phenotype and T cell receptor repertoire in patients with major depressive disorder
Patas, K., Willing, A., Demiralay, C., Engler, J. B., Lupu, A., Ramien, C., Schäfer, T., Gach, C., Stumm, L., Chan, K., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00291 · Cited by 74
Microglia and HPA axis in depression: An overview of participation and relationship
Pereira, G. C., Piton, E., dos Santos, B. M., Ramanzini, L. G., Camargo, L. F. M., da Silva, R. M., & Bochi, G. V. (2021) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2021.1939154 · Cited by 74
Johnston, J. N., Kadriu, B., Allen, J., Gilbert, J. R., Henter, I. D., & Zarate, C. A. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109422 · Cited by 75
Chesnut, M., Harati, S., Paredes, P. E., Khan, Y., Foudeh, A. M., Kim, J., Bao, Z., & Williams, L. M. (2021) · Chronic Stress · doi:10.1177/24705470211000338 · Cited by 74
Kim, J. G., Jung, H.-S., Kim, K.-J., Min, S.-S., & Yoon, B.-J. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.09.031 · Cited by 73
The development of psychotic disorders in adolescence: A potential role for hormones
Trotman, H. D., Holtzman, C. W., Ryan, A. T., Shapiro, D. I., MacDonald, A. N., Goulding, S. M., Brasfield, J. L., & Walker, E. F. (2013) · Hormones and Behavior · doi:10.1016/j.yhbeh.2013.02.018 · Cited by 73
“Among patients with mood disorders, those with psychotic symptoms manifest the greatest elevation in cortisol (Stetler and Miller, 2011).”
BackgroundEarly Life Stress in Depressive Patients: HPA Axis Response to GR and MR Agonist
Baes, C. V. W., Martins, C. M. S., Tofoli, S. M. D. C., & Juruena, M. F. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00002 · Cited by 60
Altered functioning of the HPA axis in depressed postpartum women
de Rezende, M. G., Garcia-Leal, C., de Figueiredo, F. P., Cavalli, R. D. C., Schaufelberger, M. S., Barbieri, M. A., Bettiol, H., de Castro, M., & Del‐Ben, C. M. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.12.065 · Cited by 71
“There is evidence suggesting that HPA axis dysregulation can be correlated with depressive disorders (Stetler and Miller, 2011); however, the association between HPA axis dysregulation and PPD is still controversial.”
BackgroundChildhood adversity and cognitive functioning in patients with major depression
Dannehl, K., Rief, W., & Euteneuer, F. (2017) · Child Abuse & Neglect · doi:10.1016/j.chiabu.2017.06.013 · Cited by 71
Robinson, R., Lahti‐Pulkkinen, M., Heinonen, K., Reynolds, R. M., & Räikkönen, K. (2018) · Pediatric Research · doi:10.1038/s41390-018-0173-y · Cited by 71
Fischer, S., Macare, C., & Cleare, A. J. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.10.012 · Cited by 70
“In MDD, there is evidence for multiple alterations along this axis, including elevated levels of CRH (Waters et al., 2015), elevated levels of ACTH and cortisol (Stetler and Miller, 2011), reduced glucocorticoid sensitivity (Rohleder et al., 2010), and MR/GR imbalance (de Kloet et al., 2007).”
BackgroundInfluentialJoseph, J. J., Wang, X., Spanakis, E. K., Seeman, T. E., Wand, G. S., Needham, B. L., & Golden, S. H. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.08.021 · Cited by 70
“Prior studies have shown that depressive disorders activate and alter the function of the HPA axis and increase the risk for type 2 diabetes (DM) (Stetler and Miller, 2011).”
BackgroundMind and body: how the health of the body impacts on neuropsychiatry
Renoir, T., Hasebe, K., & Gray, L. J. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00158 · Cited by 71
Allostatic load and mental health: a latent class analysis of physiological dysregulation
Carbone, J. T. (2020) · Stress · doi:10.1080/10253890.2020.1813711 · Cited by 70
“20–80% of individuals experiencing depression have some form of HPA axis hyperactivity and a half to three-quarters of depressed patients have elevated cortisol levels (Pace & Miller, 2009; Stetler and Miller, 2011).”
BackgroundLeistner, C., & Menke, A. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.01.023 · Cited by 69
Fischer, S., Ehlert, U., & Castro, R. T. A. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100792 · Cited by 69
Sex differences in cortisol levels in depression: A systematic review and meta-analysis
Wang, R., Kogler, L., & Derntl, B. (2024) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2023.101118 · Cited by 70
Neuropeptidergic regulation of pair-bonding and stress buffering: Lessons from voles
Gobrogge, K., & Wang, Z. (2015) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.08.010 · Cited by 64
“Elevated platform stress (EPS) experience increased CORT while intra-PVN-OT injections 15-minutes prior to, but not immediately following, attenuated EPS-induced-CORT, blocked c-Fos colocalization in PVN-CRH-ir neurons, and activated GABA-ir neurons instead (Smith et al., 2014a).”
BackgroundInfluentialMahmoud, R., Wainwright, S. R., Chaiton, J. A., Lieblich, S. E., & Galea, L. A. M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.01.033 · Cited by 63
“Specifically, a meta-analysis showed that 147 depressed individuals display elevated levels of serum cortisol (Stetler and Miller, 2011), and at 148 least a subset of depressed individuals show impairments in the HPA negative feedback system 149 (Ising et al., 2007; Stetler and Miller, 2011).”
BackgroundInfluentialCasaril, A. M., Domingues, M., Bampi, S. R., Lourenço, D. D. A., Padilha, N. B., Lenardao, E. J., Sonego, M. S., Seixas, F. K., Collares, T. V., Nogueira, C. W., et al. (2019) · Psychopharmacology · doi:10.1007/s00213-018-5151-x · Cited by 68
Bostock, S., & Steptoe, A. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.07.012 · Cited by 68
“For example, the magnitude of the awakening response was positively correlated with job stress in a recent meta-analysis (Chida and Steptoe, 2009); increased cortisol secretion over the day was predictive of depression (Stetler and Miller, 2011) and a flatter diurnal slope predicted cardiovascular mortality in over 40…”
Mocking, R. J. T., Pellikaan, C. M., Lok, A., Assies, J., Ruhé, H. G., Koeter, M. W., Visser, I., Bockting, C. L., Olff, M., & Schene, A. H. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.05.006 · Cited by 55
MDDScore: Confirmation of a Blood Test to Aid in the Diagnosis of Major Depressive Disorder
Bilello, J. A., Thurmond, L. M., Smith, K. M., Pi, B., Rubin, R., Wright, S. M., Taub, F., Henry, M. E., Shelton, R. C., & Papakostas, G. I. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09029 · Cited by 54
Mertens, L. J., & Preller, K. H. (2021) · Pharmacopsychiatry · doi:10.1055/a-1341-1907 · Cited by 65
“Research consistently points towards a causal role of HPA-axis dysfunction in the etiology of depression, where altered glucocorticoid receptors might lead to HPA-axis hyperactivity, hypercortisolemia, neuronal atrophy, and impaired neurogenesis down the line [21, 22].”
BackgroundSimon, L., & Admon, R. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01638-9 · Cited by 67
Bowers, K., Laughon, S. K., Kim, S., Mumford, S. L., Brite, J., Kiely, M., & Zhang, C. (2013) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12057 · Cited by 56
The association between maternal cortisol and depression during pregnancy, a systematic review
Orta, O. R., Gelaye, B., Bain, P. A., & Williams, M. A. (2017) · Archives of Women s Mental Health · doi:10.1007/s00737-017-0777-y · Cited by 67
“One such candidate pathway is the hypothalamic pituitary adrenal (HPA) axis (Pariante and Lightman 2008; Penninx et al. 2013; Knorr et al. 2010; Stetler and Miller 2011; Kino 2015).”
BackgroundDecreased Hypothalamic Functional Connectivity with Subgenual Cortex in Psychotic Major Depression
Sudheimer, K. D., Keller, J., Gomez, R. G., Tennakoon, L., Reiss, A. L., Garrett, A. S., Kenna, H. A., O'Hara, R. M., & Schatzberg, A. F. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.259 · Cited by 67
Neuroimmune and Inflammatory Signals in Complex Disorders of the Central Nervous System
Liberman, A. C., Trías, E., Chagas, L. D. S., Trindade, P., Pereira, M. D. S., Refojo, D., Hedin‐Pereira, C., & Serfaty, C. A. (2018) · NeuroImmunoModulation · doi:10.1159/000494761 · Cited by 66
Iob, E., Baldwin, J. R., Plomin, R. J., & Steptoe, A. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01538-w · Cited by 66
“Several investigations have demonstrated that depressed individuals tend to exhibit HPAaxis hyperactivation [22].”
BackgroundResultAntidepressant-Like Effects of Gyejibokryeong-hwan in a Mouse Model of Reserpine-Induced Depression
Park, B.-K., Kim, Y. R., Kim, Y. H., Yang, C., Seo, C., Jung, I. C., Jang, I., Kim, S., & Lee, M. Y. (2018) · BioMed Research International · doi:10.1155/2018/5845491 · Cited by 66
“Several hypotheses have been proposed regarding the basis of depression, including hypothalamic-pituitary-adrenal (HPA) axis hyperactivity [31]; disturbances in monoamine, glutamate, and gamma-aminobutyric acid (GABA) transmission; neurotrophic factor dysfunction; neuroinflammation [32]; and glial pathology [33, 34].”
BackgroundFeng, G., Kang, C., Yuan, J., Zhang, Y., Wei, Y., Xu, L., Zhou, F., Fan, X., & Yang, J. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.05.013 · Cited by 65
Interaction of Stress, Corticotropin-Releasing Factor, Arginine Vasopressin and Behaviour
Beurel, E., & Nemeroff, C. B. (2014) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2014_306 · Cited by 64
“seems to be associated with milder symptoms (Stetler and Miller 2011).”
BackgroundThe brain as a target of hormonal contraceptives: Evidence from animal studies
Porcu, P., Serra, M., & Concas, A. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100799 · Cited by 64
Focus on fatty acids in the neurometabolic pathophysiology of psychiatric disorders
Mocking, R. J. T., Assies, J., Ruhé, H. G., & Schene, A. H. (2018) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-018-0158-3 · Cited by 64
“…et al. 2007; Bicanic et al. 2013); depressed patients (particularly those with severe and/or melancholic depression) show HPA-axis hyperactivity thought to result from impaired HPA-axis feedback through the glucocorticoid receptor (Pariante et al. 2004; Stetler and Miller 2011; Lok et al. 2012).”
Neurobiological Links between Stress, Brain Injury, and Disease
Guo, H., Zheng, L., Xu, H., Pang, Q., Ren, Z., Gao, Y. Z., & Wang, T. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/8111022 · Cited by 64
“Many studies have shown that continuous activation of the HPA axis can lead to physiological impairments and behavioral dysfunction [62, 63].”
BackgroundWieck, A., Grassi-Oliveira, R., do Prado, C. H., Rizzo, L. B., de Oliveira, A. S., Kommers-Molina, J., Viola, T. W., Teixeira, A. L., & Bauer, M. E. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.07.005 · Cited by 63
“Although previous work demonstrated that hypothalamic-pituitary-adrenal (HPA) axis is deregulated in mood disorders (Ahrens et al., 2008; Spiliotaki et al., 2006; Stetler and Miller, 2011), the great majority of studies did not investigate stress reactivity.”
ResultDepressive Symptoms in Alzheimer’s Disease and Lewy Body Dementia: A One-Year Follow-Up Study
Fritze, F., Ehrt, U., Hortobagyi, T., Ballard, C., & Aarsland, D. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000332016 · Cited by 59
Zolbanin, J. M., Doosti, M.-H., Kosari‐Nasab, M., & Salari, A. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.03.016 · Cited by 63
“…behaviors in non-MS population or mice and depression in MS population (Abelson and Curtis, 1996, Young et al., 2004, Wallin et al., 2006, Stetler and Miller, 2011, Amani et al., 2013, Doosti et al., 2013, Babri et al., 2014a) and also increased disease progression in MS patients because…”
Murri, M. B., Folesani, F., Zerbinati, L., Nanni, M. G., Ounalli, H., Caruso, R., & Grassi, L. G. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17155545 · Cited by 64
“In particular, dysregulation of the HPA axis is one of the most consistent biological alterations associated with depression [33], particularly in old age [34], with possible differences according to the melancholic or atypical subtype [35].”
BackgroundWang, H., Zhou, X., Huang, J., Mu, N., Guo, Z., Wen, Q. J., Wang, R., Chen, S., Feng, Z., & Zheng, W. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3017-9 · Cited by 62
“In recent years, a large number of experimental and clinical observations have supported the notion that some depression patients are characterized by an over activity of the hypothalamic–pituitary–adrenal (HPA) axis (Guerry and Hastings 2011; Stetler and Miller 2011).”
Horowitz, M. A., Cattaneo, A., Cattane, N., Lopizzo, N., Tojo, L. M., Bakunina, N., Musaelyan, K., Borsini, A., Zunszain, P. A., & Pariante, C. M. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.03.012 · Cited by 62
“Our findings suggest a mechanism by which glucocorticoids, thought to contribute to the pathogenesis of depression (Stetler and Miller, 2011), may synergise with inflammation to contribute to the pathogenesis of depression, rather than being solely counter-regulatory to”
BackgroundLeft brain cortical activity modulates stress effects on social behavior
Lee, E., Hong, J., Park, Y.-G., Chae, S., Kim, Y. D., & Kim, D. (2015) · Scientific Reports · doi:10.1038/srep13342 · Cited by 62
Neuroendocrine Aspects of Tourette Syndrome
Martino, D., Macerollo, A., & Leckman, J. F. (2013) · International review of neurobiology · doi:10.1016/b978-0-12-411546-0.00009-3 · Cited by 62
The brain-adipocyte-gut network: Linking obesity and depression subtypes
Patist, C., Stapelberg, N. J. C., Toit, E. F. D., & Headrick, J. P. (2018) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-018-0626-0 · Cited by 62
“There is some evidence of neurophysiological distinctions between MDD-AF and MDD, although findings are equivocal with substantial overlap in features, and how these contribute to distinct behavioural and obesity outcomes in MDD-AF versus MDD-MF is unclear.”
ResultInfluentialStolfi, F., Abreu, H., Sinella, R., Nembrini, S., Centonze, S., Landra, V., Brasso, C., Cappellano, G., Rocca, P., & Chiocchetti, A. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1422939 · Cited by 63
Heterogeneity in HPA axis dysregulation and serotonergic vulnerability to depression
Ancelin, M.-L., Scali, J., Norton, J., Ritchie, K., Dupuy, A.-M., Chaudieu, I., & Ryan, J. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.11.016 · Cited by 61
“…secretion is not only a good indicator of HPA responsivity and differential biological response to short-term versus long-term effect of stress (Miller et al., 2007; Morris et al., 2012) but it also constitutes one important neurobiological characteristic of depression (Stetler and Miller, 2011).”
Wigman, J. T. W., van Os, J., Abidi, L., Huibers, M. J. H., Roelofs, J., Arntz, A., Kelleher, I., & Peeters, F. P. M. L. (2014) · Psychological Medicine · doi:10.1017/s0033291713000871 · Cited by 58
Why Severe COVID-19 Patients Are at Greater Risk of Developing Depression: A Molecular Perspective
Bouças, A. P., Rheinheimer, J., & Lagopoulos, J. (2020) · The Neuroscientist · doi:10.1177/1073858420967892 · Cited by 61
Use of antipsychotics in the treatment of depressive disorders.
Wang, P., & Si, T. (2013) · PubMed Central · doi:10.3969/j.issn.1002-0829.2013.03.002 · Cited by 61
Wainwright, S. R., Workman, J. L., Tehrani, A. R., Hamson, D. K., Chow, C., Lieblich, S. E., & Galea, L. A. M. (2016) · Hormones and Behavior · doi:10.1016/j.yhbeh.2016.01.001 · Cited by 60
Musil, R., Seemüller, F., Meyer, S., Spellmann, I., Adli, M., Bauer, M., Kronmüller, K., Brieger, P., Laux, G., Bender, W., et al. (2018) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1569 · Cited by 54
“…in immune functions (for review see Antonijevic, 2006; Gold & Chrousos, 1999, 2002; Gold, Licinio, Wong, & Chrousos, 1995; Leventhal & Rehm, 2005; Stetler & Miller, 2011; Stewart, McGrath, Quitkin, & Klein, 2009) or differential involvement of prefrontal cortex (PFC) (Gold & Chrousos, 2002)…”
Is the Brain a Key Player in Glucose Regulation and Development of Type 2 Diabetes?
Lundqvist, M., Almby, K. E., Abrahamsson, N., & Eriksson, J. W. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00457 · Cited by 60
Sun, X., Zhang, T., Zhao, Y. H., Cai, E., Zhu, H., & Liu, S. (2020) · Food & Function · doi:10.1039/c9fo03104a · Cited by 59
Psychosocial distress and inflammation: Which way does causality flow?
Das, A. (2016) · Social Science & Medicine · doi:10.1016/j.socscimed.2016.10.001 · Cited by 59
Longitudinal effects of the SSRI paroxetine on salivary cortisol in Major Depressive Disorder
Ruhé, H. G., Khoenkhoen, S. J., Ottenhof, K. W., Koeter, M. W., Mocking, R. J. T., & Schene, A. H. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.10.024 · Cited by 49
Desai, V., Kozyrskyj, A. L., Lau, S., Sanni, O. B., Dennett, L., Walter, J., & Ospina, M. B. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.622181 · Cited by 59
Hardeveld, F., Spijker, J., Vreeburg, S. A., Graaf, R. D., Hendriks, S. M., Licht, C. M. M., Nolen, W. A., Penninx, B. W. J. H., & Beekman, A. T. F. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.07.027 · Cited by 58
Walker, A. J., Foley, B. M., Sutor, S. L., McGillivray, J. A., Frye, M. A., & Tye, S. J. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.07.026 · Cited by 56
“A meta-analysis conducted by Stetler and Miller (2011) examining dysregulation of the HPA axis in studies of patients with depression, found adrenocorticotropic hormone (ACTH) to be a reliable etiological disease substrate.”
BackgroundMethodJiang, Y., Peng, T., Gaur, U., Silva, M., Little, P. J., Chen, Z., Qiu, W., Zhang, Y., & Zheng, W. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00290 · Cited by 58
“With increasing age, patients with depression show a greater change on the HPA axis activity compared to people without depression, especially in circulating cortisol and ACTH levels (Stetler and Miller, 2011; Belvederi Murri et al., 2014).”
BackgroundLever-van Milligen, B. A., Verhoeven, J. E., Schmaal, L., van Velzen, L. S., Révész, D., Black, C. N., Han, L. K. M., Horsfall, M., Batelaan, N. M., van Balkom, A. J. L. M., et al. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2404-0 · Cited by 51
Popović, D., Bjelobrk, M., Tesic, M. B., Seman, S., Jayasinghe, S. U., Hills, A. P., Babu, A. S., Jakovljević, D. G., Stoner, L. R., Ozemek, C., et al. (2022) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2022.01.008 · Cited by 58
Psychological, endocrine and neural responses to social evaluation in subclinical depression
Dedovic, K., Duchesne, A., Engert, V., Lue, S. D., Andrews, J., Efanov, S. I., Beaudry, T., & Pruessner, J. C. (2013) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nst151 · Cited by 59
Travis, S. G., Coupland, N. J., Hegadoren, K., Silverstone, P. H., Huang, Y., Carter, R., Fujiwara, E., Seres, P., & Malykhin, N. V. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.04.049 · Cited by 57
“However, the recent meta-analyses pointed to the modest effect size and the large heterogeneity of results (Knorr et al., 2010; Stetler and Miller, 2011).”
BackgroundResultInfluentialSalivary cortisol measurement in developmental research: where do we go from here?
Clements, A. D. (2013) · Developmental Psychobiology · doi:10.1002/dev.21025 · Cited by 57
Bockting, C. L. H., Lok, A., Visser, I., Assies, J., Koeter, M. W., & Schene, A. H. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.03.044 · Cited by 57
“There have been at least 361 studies performed that compared HPA axis function between depressed and non-depressed individuals, however few studies examined the predictive value of the HPA activity on course in recurrent and chronic depression (for a meta-analysis see Stetler and Miller, 2011).”
Cognitive Risks in Developmental Psychopathology
Hankin, B. L., Snyder, H. R., & Gulley, L. D. (2016) · Developmental Psychopathology · doi:10.1002/9781119125556.devpsy308 · Cited by 53
“Since chronic stress and elevated cortisol have been linked to many forms of psychopathology (e.g., adult depression, (Stetler & Miller, 2011); schizophrenia, (Walker, Mittal, & Tessner, 2008), this is a plausible pathway for neurodegeneration and subsequent cognitive deficits associated with…”
BackgroundChanges in leukocytes and CRP in different stages of major depression
Singh, D., Guest, P. C., Dobrowolny, H., Vasilevska, V., Meyer-Lotz, G., Bernstein, H., Borucki, K., Neyazi, A., Bogerts, B., Jacobs, R., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02429-7 · Cited by 57
Høifødt, R. S., Waterloo, K. K., Wang, C. E. A., Eisemann, M. R., Figenschau, Y., & Halvorsen, M. B. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.08.024 · Cited by 57
Adaptogenic property of Asparagus racemosus: Future trends and prospects
Singh, N., Garg, M., Prajapati, P., Singh, P. K., Chopra, R., Kumari, A., & Mittal, A. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e14932 · Cited by 57
Arnaldo, I., Corcoran, A. W., Friston, K. J., & Ramstead, M. J. D. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104590 · Cited by 56
“Atypical depression is characterized by a hypoactive HPA system, whereas melancholic depression is associated with a hyperactive HPA system (Lamers et al., 2013; Stetler and Miller, 2011).”
Metadata
- Authors
- Stetler, C., & Miller, G. E.
- Affiliations
- Furman University (US)
- University of British Columbia (CA)
- Corresponding author
- Stetler, Cinnamon
- ORCID
- Miller, Gregory E.
- Venue
- Psychosomatic Medicine
- Published
- 2011-02
- Volume
- 73
- Issue
- 2
- Pages
- 114-126
- ISSN
- 0033-3174 (ISSN-L)
- OpenAlex
- W2325341530
- Semantic Scholar
- 8dd36c89fdc21f4d365839c99e1ae8e38ebdcccb
- Cited by
- 1,123
- References
- 32
- Citations by year
- 2026: 54 · 2025: 62 · 2024: 56 · 2023: 84 · 2022: 96 · 2021: 100 · 2020: 90 · 2019: 85 · 2018: 81 · 2017: 69 · 2016: 95 · 2015: 70 · 2014: 61 · 2013: 59 · 2012: 40
- FWCI
- 22.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychosomatic Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- depression, hypothalamic-pituitary-adrenal axis, cortisol, ACTH, corticotropin-releasing factor, atypical depression, endogenous depression, psychotic depression, hospitalized older adults, methodological quality, gender differences
- MeSH terms
- Adolescent, Adrenocorticotropic Hormone, Adult, Child, Corticotropin-Releasing Hormone, Depressive Disorder, Female, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Male, Middle Aged, Pituitary-Adrenal System, Research, Bibliometrics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.